Answer
It treats selected adults with AChR-antibody-positive generalised myasthenia gravis alongside standard therapy. The subcutaneous formulation is also licensed for selected adults with active CIDP after previous corticosteroid or immunoglobulin treatment.
Sources for this answer
- Vyvgart 1000 mg solution for injection in pre-filled syringeemc · SmPC Current selected SmPC · Version 2
- Vyvgart 20 mg/mL concentrate for solution for infusion